Abstract
Neuropeptides control a wide spectrum of physiological functions. They are central to our understanding of brain functions. They exert their actions by interacting with specific G protein-coupled receptors. We however have not found all the neuropeptides that exist in organisms. The search for novel neuropeptides is thus of great interest as it will lead to a better understanding of brain function and disorders. In this review, we will discuss the historical as well as the current approaches to neuropeptide discovery, with a particular emphasis on the orphan GPCR-based strategies. We will also discuss two novel peptides, neuropeptide S and neuromedin S, as examples of the impact of neuropeptide discovery on our understanding of brain functions. Finally, the challenges facing neuropeptide discovery will be discussed.
Keywords: Neuropeptide, Orphan GPCR, Neuropeptide S, Neuromedin S, neurotransmitters, homeostasis, caffeine, signal transduction, amino ac, suprachiasmatic nucleus (SCN), secondary, angiogenesis, neurogenesis, functional, recovery, endogenuis, exogenius, factors, dedifferentiation, pluripotent, multipotent, Proliferation, Survival, Precursor cells
Current Pharmaceutical Design
Title: Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors
Volume: 17 Issue: 25
Author(s): Yan Zhang, Zhiwei Wang, Gregory Scott Parks and Olivier Civelli
Affiliation:
Keywords: Neuropeptide, Orphan GPCR, Neuropeptide S, Neuromedin S, neurotransmitters, homeostasis, caffeine, signal transduction, amino ac, suprachiasmatic nucleus (SCN), secondary, angiogenesis, neurogenesis, functional, recovery, endogenuis, exogenius, factors, dedifferentiation, pluripotent, multipotent, Proliferation, Survival, Precursor cells
Abstract: Neuropeptides control a wide spectrum of physiological functions. They are central to our understanding of brain functions. They exert their actions by interacting with specific G protein-coupled receptors. We however have not found all the neuropeptides that exist in organisms. The search for novel neuropeptides is thus of great interest as it will lead to a better understanding of brain function and disorders. In this review, we will discuss the historical as well as the current approaches to neuropeptide discovery, with a particular emphasis on the orphan GPCR-based strategies. We will also discuss two novel peptides, neuropeptide S and neuromedin S, as examples of the impact of neuropeptide discovery on our understanding of brain functions. Finally, the challenges facing neuropeptide discovery will be discussed.
Export Options
About this article
Cite this article as:
Zhang Yan, Wang Zhiwei, Scott Parks Gregory and Civelli Olivier, Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors, Current Pharmaceutical Design 2011; 17 (25) . https://dx.doi.org/10.2174/138161211797416110
DOI https://dx.doi.org/10.2174/138161211797416110 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology
Current Drug Metabolism Chickpea (Cicer arietinum L.) Lectin Exhibit Inhibition of ACE-I, α-amylase and α-glucosidase Activity
Protein & Peptide Letters Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (LOX-1) in Atherogenesis: A Brief Review
Current Medicinal Chemistry Beta-Blocking Agents and Electroconvulsive Therapy
Current Drug Therapy Obstructive Sleep Apnea and Atrial Arrhythmogenesis
Current Cardiology Reviews Socio-economic Aspects of Alzheimer's Disease
Current Alzheimer Research ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis
Current Vascular Pharmacology Closing in on Biliary Atresia
Current Pediatric Reviews The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature
Current Rheumatology Reviews Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Current Medicinal Chemistry Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss
Current Neuropharmacology Development and Validation of a Simple High-Performance Liquid Chromatography Method for Estimation of Felodipine in Rabbit Plasma: Application to Pharmacokinetic Study
Current Pharmaceutical Analysis A Review on Analytical Methods of Irbesartan and its Combinations in Pharmaceutical Dosage Forms
Current Pharmaceutical Analysis Surgical Treatment of Neonatal Mastitis by Periareolar Drainage
Current Pediatric Reviews Fat Digestion and its Role in Appetite Regulation and Energy Balance -The Importance of Enterostatin and Tetrahydrolipstatin
Current Medicinal Chemistry - Central Nervous System Agents FDG-PET Scanning Shows Distributed Changes in Cortical Activity Associated with Visual Hallucinations in Eye Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Nanotechnology can Provide Therapeutic Agent by Targeting Molecular Structures of SARS-CoV-2 (COVID-19): A Mini-Review
Letters in Drug Design & Discovery Nebulizable Cycloserine Loaded PLGA Nanoparticles: Formulation Design, in vitro Evaluation and Stability Studies
Current Nanomedicine Diabetes, Oxidative Stress, Nitric Oxide and Mitochondria Function
Current Diabetes Reviews Editorial (Thematic Issue: NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities)
Current Pharmaceutical Design